Acute promyelocytic leukemia (APL) is a hyper-acute illness and presents with profound
cytopenias in most patients and disseminated intravascular coagulation (DIC). Excellent …

Background Early death is a major factor of treatment failure in acute promyelocytic
leukemia (APL), however, the recent trends in the incidence of early death based on the …

Improvements in clinical assessment have occurred since the last published
recommendations on the diagnosis and treatment of acute promyelocytic leukemia in 2013 …

Background and Aims The biological characterization of childhood acute myeloid leukemia
(c-AML) is an important outcome predictor. In Brazil, very little is known about the frequency …

Summary The Latin Americas and Caribbean are regions where social exclusion and
inequality persist as the main obstacles to human development and improvement of health …

Improvements in clinical assessment have occurred since the last published
recommendations on the diagnosis and treatment of acute promyelocytic leukemia in 2013 …

Previous studies have suggested a variation in the incidence of acute promyelocytic
leukemia (APL) among the geographic regions with relatively higher percentages in the …

Acute promyelocytic leukemia (APL) during pregnancy is rare and difficult to treat. To the
best of our knowledge, there is little precedent for successful treatment with combined …

Aims and Objectives: We analyzed CD 34 and HLA-DR dual-negative acute myeloid
leukemia (AML) cases presented to us over 2.5 years (26 cases) and segregated them into …

Objective: To evaluate factors predictive for relapse in a cohort of adult patients with acute
promyelocytic leukemia monitored by molecular methods during consolidation and during at …